Horan Securities’s Silk Road Medical, Inc. Common Stock SILK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-869
Closed -$28.2K 706
2023
Q2
$28.2K Hold
869
0.01% 283
2023
Q1
$34K Hold
869
0.02% 253
2022
Q4
$45.9K Hold
869
0.03% 216
2022
Q3
$39K Hold
869
0.02% 208
2022
Q2
$34K Hold
869
0.02% 211
2022
Q1
$36K Hold
869
0.02% 207
2021
Q4
$37K Buy
+869
New +$43.5K 0.02% 200
2021
Q2
$32K Hold
669
0.02% 201
2021
Q1
$34K Hold
669
0.03% 178
2020
Q4
$42K Buy
669
+385
+136% +$23.9K 0.03% 139
2020
Q3
$19K Sell
284
-460
-62% -$25.1K 0.02% 171
2020
Q2
$31K Hold
744
0.03% 100
2020
Q1
$23K Buy
+744
New +$29.8K 0.03% 97
2019
Q4
Sell
-1,014
Closed -$33K 237
2019
Q3
$33K Buy
+1,014
New +$40.4K 0.04% 97

Other funds holding SILK

Horan Securities's SILK Position: Q3 2023 in Review

Horan Securities sold out of Silk Road Medical, Inc. Common Stock (SILK) in Q3 2023, closing a stake of 869 shares — an estimated $28.2K sold.

Horan Securities first reported a position in SILK in Q3 2019 and held it in 14 quarters. The position peaked at $45.9K in Q4 2022. 166 funds tracked by Wall St. Rank hold SILK as of Q3 2023.

  • Horan Securities reported no remaining Silk Road Medical, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
  • Horan Securities sold 869 Silk Road Medical, Inc. Common Stock shares in Q3 2023, an estimated $28.2K.
  • Horan Securities first reported a position in Silk Road Medical, Inc. Common Stock in Q3 2019 and held it in 14 quarters.
  • Horan Securities's Silk Road Medical, Inc. Common Stock position peaked at $45.9K in Q4 2022.
  • 166 funds tracked by Wall St. Rank held Silk Road Medical, Inc. Common Stock as of Q3 2023.

Based on Horan Securities's 13F filing for Q3 2023, filed 1 Nov 2023.